Cargando…

Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection

BACKGROUND: Limited literature exists that evaluated outcomes of kidney transplant–eligible patients who are having dialysis and who are undergoing valve replacement. Our main objective in this study was to compare mortality, reoperation, and bleeding episodes between bioprosthetic and mechanical va...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngendahimana, David K., Deo, Salil V., Sundaram, Varun, Lentine, Krista L., Herzog, Charles A., Al Dahabreh, Laith, Srinivas, Titte R., Chavin, Kenneth D., Sarabu, Nagaraju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174273/
https://www.ncbi.nlm.nih.gov/pubmed/33599143
http://dx.doi.org/10.1161/JAHA.120.018971
_version_ 1783702872850956288
author Ngendahimana, David K.
Deo, Salil V.
Sundaram, Varun
Lentine, Krista L.
Herzog, Charles A.
Al Dahabreh, Laith
Srinivas, Titte R.
Chavin, Kenneth D.
Sarabu, Nagaraju
author_facet Ngendahimana, David K.
Deo, Salil V.
Sundaram, Varun
Lentine, Krista L.
Herzog, Charles A.
Al Dahabreh, Laith
Srinivas, Titte R.
Chavin, Kenneth D.
Sarabu, Nagaraju
author_sort Ngendahimana, David K.
collection PubMed
description BACKGROUND: Limited literature exists that evaluated outcomes of kidney transplant–eligible patients who are having dialysis and who are undergoing valve replacement. Our main objective in this study was to compare mortality, reoperation, and bleeding episodes between bioprosthetic and mechanical valve procedures among kidney transplant–eligible patients who are having dialysis. METHODS AND RESULTS: We studied 887 and 1925 dialysis patients from the United States Renal Data System, who underwent mitral valve replacement and aortic valve replacement (AVR) after being waitlisted for a kidney transplant (2000–2015), respectively. Time to death, time to reoperation, and time to bleeding requiring hospitalizations were compared separately for AVR and mitral valve replacement. Kaplan–Meier survival curves, Cox proportional hazards model for time to death, accelerated time to event model for time to reoperation, and counting process model for time to recurrent bleeding were used. There were no differences in mortality (hazard ratio [HR], 0.92; 95% CI, 0.77–1.09) or risk of reoperation or risk of significant bleeding events between bioprosthetic and mechanical mitral valve replacement. However, mechanical AVR was associated with a modestly significant less hazard of death (HR, 0.83; 95% CI, 0.74–0.94) compared with bioprosthetic AVR. There were no differences in time to reoperation, or time to significant bleeding events between bioprosthetic and mechanical AVR. CONCLUSIONS: For kidney transplant waitlisted patients who are on dialysis and who are undergoing surgical valve replacement, bioprosthetic and mechanical valves have comparable survival, reoperation rates, and bleeding episodes requiring hospitalizations at both mitral and aortic locations. These findings emphasize that an individualized informed decision is recommended when choosing the type of valve for this special group of patients having dialysis.
format Online
Article
Text
id pubmed-8174273
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81742732021-06-11 Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection Ngendahimana, David K. Deo, Salil V. Sundaram, Varun Lentine, Krista L. Herzog, Charles A. Al Dahabreh, Laith Srinivas, Titte R. Chavin, Kenneth D. Sarabu, Nagaraju J Am Heart Assoc Original Research BACKGROUND: Limited literature exists that evaluated outcomes of kidney transplant–eligible patients who are having dialysis and who are undergoing valve replacement. Our main objective in this study was to compare mortality, reoperation, and bleeding episodes between bioprosthetic and mechanical valve procedures among kidney transplant–eligible patients who are having dialysis. METHODS AND RESULTS: We studied 887 and 1925 dialysis patients from the United States Renal Data System, who underwent mitral valve replacement and aortic valve replacement (AVR) after being waitlisted for a kidney transplant (2000–2015), respectively. Time to death, time to reoperation, and time to bleeding requiring hospitalizations were compared separately for AVR and mitral valve replacement. Kaplan–Meier survival curves, Cox proportional hazards model for time to death, accelerated time to event model for time to reoperation, and counting process model for time to recurrent bleeding were used. There were no differences in mortality (hazard ratio [HR], 0.92; 95% CI, 0.77–1.09) or risk of reoperation or risk of significant bleeding events between bioprosthetic and mechanical mitral valve replacement. However, mechanical AVR was associated with a modestly significant less hazard of death (HR, 0.83; 95% CI, 0.74–0.94) compared with bioprosthetic AVR. There were no differences in time to reoperation, or time to significant bleeding events between bioprosthetic and mechanical AVR. CONCLUSIONS: For kidney transplant waitlisted patients who are on dialysis and who are undergoing surgical valve replacement, bioprosthetic and mechanical valves have comparable survival, reoperation rates, and bleeding episodes requiring hospitalizations at both mitral and aortic locations. These findings emphasize that an individualized informed decision is recommended when choosing the type of valve for this special group of patients having dialysis. John Wiley and Sons Inc. 2021-02-18 /pmc/articles/PMC8174273/ /pubmed/33599143 http://dx.doi.org/10.1161/JAHA.120.018971 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Ngendahimana, David K.
Deo, Salil V.
Sundaram, Varun
Lentine, Krista L.
Herzog, Charles A.
Al Dahabreh, Laith
Srinivas, Titte R.
Chavin, Kenneth D.
Sarabu, Nagaraju
Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_full Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_fullStr Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_full_unstemmed Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_short Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection
title_sort outcomes of surgical mitral and aortic valve replacements among kidney transplant candidates: implications for valve selection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174273/
https://www.ncbi.nlm.nih.gov/pubmed/33599143
http://dx.doi.org/10.1161/JAHA.120.018971
work_keys_str_mv AT ngendahimanadavidk outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT deosalilv outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT sundaramvarun outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT lentinekristal outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT herzogcharlesa outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT aldahabrehlaith outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT srinivastitter outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT chavinkennethd outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection
AT sarabunagaraju outcomesofsurgicalmitralandaorticvalvereplacementsamongkidneytransplantcandidatesimplicationsforvalveselection